CSIC has developed ENGAGE, engineered bacteria with cell adhesion specificity and programmed delivery of therapeutic proteins into the cytoplasm of target mammalian cells
Industrial partners from the ophthalmic or pharmaceutical industry are being sought to collaborate through a patent licence agreement.
Material de descarga
More information here